P. Mason

发表

RNA interference screen for human genes associated with West Nile virus infection

Ruth R. Montgomery, R. Xavier, A. Brass, 2008, Nature.

Genetic Determinants of Altered Virulence of Taiwanese Foot-and-Mouth Disease Virus

P. Mason, C. Beard, 2000, Journal of Virology.

Role of Nonstructural Proteins 3A and 3B in Host Rangeand Pathogenicity of Foot-and-Mouth DiseaseVirus

P. Mason, V. O'Donnell, J. Pacheco, 2003, Journal of Virology.

Molecular basis of pathogenesis of FMDV.

P. Mason, B. Baxt, M. Grubman, 2003, Virus research.

Engineered alphavirus replicon vaccines based on known attenuated viral mutants show limited effects on immunogenicity.

P. Mason, C. Beard, Giulietta Maruggi, 2013, Virology.

Procedures for preventing the transmission of foot-and-mouth disease virus to pigs and sheep by personnel in contact with infected pigs

P. Mason, J. Pacheco, S. Amass, 2003, Veterinary Record.

West Nile Virus Infection Activates the Unfolded Protein Response, Leading to CHOP Induction and Apoptosis

P. Mason, K. Früh, W. Lipkin, 2007, Journal of Virology.

Procedures for preventing transmission of foot-and-mouth disease virus (O/TAW/97) by people.

P. Mason, J. Pacheco, S. J. Kenyon, 2004, Veterinary microbiology.

Sequence of the dengue-1 virus genome in the region encoding the three structural proteins and the major nonstructural protein NS1.

P. Mason, P. Mcada, T. Mason, 1987, Virology.

Animal-derived antigenic variants of foot-and-mouth disease virus type A12 have low affinity for cells in culture

P. Mason, B. Baxt, E. Rieder, 1994, Journal of virology.

Foot-and-Mouth Disease Virus Virulent for Cattle Utilizes the Integrin αvβ3 as Its Receptor

P. Mason, E. Brown, S. Blystone, 1998, Journal of Virology.

Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells

P. Mason, 1989, Virology.

Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection.

E. Paoletti, P. Mason, R. Shope, 1991, Virology.

Out on the farm with DNA vaccines

P. Mason, C. Beard, 1998, Nature Biotechnology.

Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor.

E. Wimmer, P. Mason, F. Brown, 1993, Virology.

Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle

P. Mason, A. Tanuri, B. Baxt, 1997, Journal of virology.

Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor.

P. Mason, E. Brown, S. Blystone, 1998, Journal of virology.

Construction and characterization of a stable subgenomic replicon system of a Brazilian dengue virus type 3 strain (BR DEN3 290-02).

P. Mason, A. L. Mosimann, C. D. D. dos Santos, 2010, Journal of virological methods.

Construction of an infectious cDNA clone for a Brazilian prototype strain of dengue virus type 1: characterization of a temperature-sensitive mutation in NS1.

P. Mason, C. N. Duarte Dos Santos, R. Suzuki, 2007, Virology.

Improving influenza virus backbones by including terminal regions of MDCK-adapted strains on hemagglutinin and neuraminidase gene segments.

P. Dormitzer, P. Mason, G. Palladino, 2013, Vaccine.

RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway.

P. Mason, B. Baxt, E. Rieder, 1994, Proceedings of the National Academy of Sciences of the United States of America.

RNA Virus Families: Distinguishing Characteristics, Differences, and Similarities

P. Mason, F. Scholle, 2009 .

Detecting Plasmodium falciparum in community surveys: a comparison of Paracheck Pf® Test and ICT Malaria Pf® Cassette Test to polymerase chain reaction in Mutasa District, Zimbabwe

P. Mason, S. Munyati, A. Makuwaza, 2021, Malaria journal.

Subunit 3 β Dependent on the Bovine Foot-and-Mouth Disease Virus Is as a Receptor for 3 β v α Integrin High-Efficiency Utilization of the Bovine

P. Mason, B. Baxt, S. Neff, 2000 .

High-Efficiency Utilization of the Bovine Integrin αvβ3 as a Receptor for Foot-and-Mouth Disease Virus Is Dependent on the Bovine β3Subunit

P. Mason, B. Baxt, S. Neff, 2000, Journal of Virology.

Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin

P. Mason, S. Bertholet, E. De Gregorio, 2015, Journal of Virology.

Resistance to Alpha/Beta Interferon Is a Determinant of West Nile Virus Replication Fitness and Virulence

M. Diamond, P. Mason, M. Gale, 2006, Journal of Virology.

Foot-and-Mouth Disease Virus-Receptor Interactions: Role in Pathogenesis and Tissue Culture Adaptation

P. Mason, B. Baxt, E. Rieder, 2002 .

Early Production of Type I Interferon during West Nile Virus Infection: Role for Lymphoid Tissues in IRF3-Independent Interferon Production

P. Mason, N. Bourne, D. Estes, 2007, Journal of Virology.

Membrane association and secretion of the Japanese encephalitis virus NS1 protein from cells expressing NS1 cDNA.

P. Mason, W. Fan, 1990, Virology.

West Nile Virus Capsid Degradation of Claudin Proteins Disrupts Epithelial Barrier Function

P. Mason, C. Wiley, J. Nelson, 2009, Journal of Virology.

against Lethal West Nile Virus Responses in Old Mice Generates Protective Repeated In Vivo Stimulation of T and B Cell

P. Mason, D. Widman, J. Nikolich-Žugich, 2011 .

Studies of genetically defined chimeras of a European type A virus and a South African Territories type 2 virus reveal growth determinants for foot-and-mouth disease virus.

P. Mason, T. Henry, H. V. van Rensburg, 2004, The Journal of general virology.

Construction and evaluation of an attenuated vaccine for foot-and-mouth disease: difficulty adapting the leader proteinase-deleted strategy to the serotype O1 virus.

P. Mason, C. Beard, E. Rieder, 1998, Virus research.

Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice

P. Mason, F. Brown, E. Rieder, 1993, Journal of virology.

Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD

P. Mason, B. Baxt, J. Lubroth, 1995, Journal of virology.

Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus.

P. Mason, B. Baxt, E. Rieder, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Persistent infections of mammals and mammalian cell cultures with West Nile virus

P. Mason, S. Rossi, 2008 .

Nonviral delivery of self-amplifying RNA vaccines

Thomas Krucker, Rino Rappuoli, Yen Cu, 2012, Proceedings of the National Academy of Sciences.

Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice.

P. Mason, J. Ulmer, C. Schmaljohn, 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

TLR3- and MyD88-Dependent Signaling Differentially Influences the Development of West Nile Virus-Specific B Cell Responses in Mice following Immunization with RepliVAX WN, a Single-Cycle Flavivirus Vaccine Candidate

P. Mason, G. Milligan, E. Winkelmann, 2013, Journal of Virology.

Vaccine Candidate RepliVAX WN , a Single-Cycle Flavivirus in Mice following Immunization with West Nile Virus-Specific B Cell Responses ofDifferentially Influences the Development TLR 3-and MyD 88-Dependent Signaling

P. Mason, G. Milligan, E. Winkelmann, 2013 .

Emergence in Asia of Foot-and-Mouth Disease Viruses with Altered Host Range: Characterization of Alterations in the 3A Protein

P. Mason, V. O'Donnell, J. Pacheco, 2001, Journal of Virology.

Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine

P. Mason, E. Rieder, G. Ward, 1997, Journal of virology.

RNA-based vaccines.

C. Mandl, P. Mason, J. Ulmer, 2012, Vaccine.

Potentiation of West Nile encephalitis by mosquito feeding.

S. Higgs, P. Mason, B. S. Schneider, 2006, Viral immunology.

Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection.

P. Mason, R. Shope, T. Frey, 1995, Virology.

Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus

P. Mason, M. Grubman, J. Chinsangaram, 1998, Vaccine.

Antibody Response in Mice Inoculated with DNA Expressing Foot-and-Mouth Disease Virus Capsid Proteins

P. Mason, C. Beard, M. Grubman, 1998, Journal of Virology.

Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies.

C. Mandl, P. Mason, R. Loomis, 2013, Vaccine.

Infection, dissemination, and transmission of a West Nile virus green fluorescent protein infectious clone by Culex pipiens quinquefasciatus mosquitoes.

S. Higgs, P. Mason, D. Vanlandingham, 2010, Vector borne and zoonotic diseases.

Discovery of small molecule inhibitors of West Nile virus using a high-throughput sub-genomic replicon screen.

P. Mason, Baohua Gu, N. Bourne, 2006, Antiviral research.

trans-Packaged West Nile Virus-Like Particles: Infectious Properties In Vitro and in Infected Mosquito Vectors

S. Higgs, P. Mason, F. Scholle, 2004, Journal of Virology.

Subcapsular sinus macrophages limit dissemination of West Nile virus particles after inoculation but are not essential for the development of West Nile virus-specific T cell responses.

Alison Johnson, P. Mason, D. Widman, 2014, Virology.

Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.

E. Konishi, P. Mason, I. Kurane, 2000, Virology.

Conjugation to nickel-chelating nanolipoprotein particles increases the potency and efficacy of subunit vaccines to prevent West Nile encephalitis.

T. Ishikawa, P. Mason, P. Hoeprich, 2010, Bioconjugate chemistry.

Evaluation of infectivity and transmission of different Asian foot-and-mouth disease viruses in swine

P. Mason, J. Pacheco, 2010, Journal of veterinary science.

Transformation of an insect symbiont and expression of a foreign gene in the Chagas' disease vector Rhodnius prolixus.

C. Beard, R. Tesh, P. Mason, 1992, The American journal of tropical medicine and hygiene.

Induction of Protective Immunity against Japanese Encephalitis in Mice by Immunization with a Plasmid Encoding Japanese Encephalitis Virus Premembrane and Envelope Genes

E. Konishi, P. Mason, I. Kurane, 1998, Journal of Virology.

Antiviral activity of geneticin against dengue virus.

P. Mason, N. Bourne, E. Dubovi, 2009, Antiviral research.

Prenatal transmission of subtype C HIV-1 in Zimbabwe: HIV-1 RNA and DNA in maternal and cord blood.

D. Katzenstein, P. Mason, C. Contag, 2000 .

Evaluation of RepliVAX WN, a single-cycle flavivirus vaccine, in a non-human primate model of West Nile virus infection.

T. Ishikawa, R. Tesh, P. Mason, 2010, The American journal of tropical medicine and hygiene.

Generation of a parvovirus B19 vaccine candidate.

C. Mandl, E. Settembre, P. Dormitzer, 2013, Vaccine.

Particulate vaccine candidate for Japanese encephalitis induces long-lasting virus-specific memory T lymphocytes in mice.

E. Konishi, F. Ennis, P. Mason, 1997, Vaccine.

Human RNA Polymerase I-Driven Reverse Genetics for Influenza A Virus in Canine Cells

P. Dormitzer, P. Mason, M. Franti, 2010, Journal of Virology.

The NS5 Protein of the Virulent West Nile Virus NY99 Strain Is a Potent Antagonist of Type I Interferon-Mediated JAK-STAT Signaling

A. Barrett, W. L. Shupert, P. Mason, 2010, Journal of Virology.

The foot-and-mouth disease virus leader proteinase gene is not required for viral replication

P. Mason, E. Rieder, M. Grubman, 1995, Journal of virology.

Production and characterization of vaccines based on flaviviruses defective in replication.

P. Mason, I. Frolov, A. Shustov, 2006, Virology.

Chapter 22 – Foot-and-Mouth Disease

P. Mason, M. Grubman, 2009 .

Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.

P. Mason, G. Mayr, M. Grubman, 2002, Vaccine.

Prospects, including time-frames, for improved foot and mouth disease vaccines.

P. Mason, M. Grubman, 2002, Revue scientifique et technique.

Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs.

P. Mason, G. Mayr, V. O'Donnell, 2001, Vaccine.

Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine.

P. Mason, C. Beard, E. Rieder, 1999, Journal of biotechnology.

High-Efﬁciency Utilization of the Bovine Integrin a v b 3 as a Receptor for Foot-and-Mouth Disease Virus Is Dependent on the Bovine b 3 Subunit

P. Mason, B. Baxt, S. Neff, 2000 .

Production of Pseudoinfectious Yellow Fever Virus with a Two-Component Genome

P. Mason, I. Frolov, A. Shustov, 2007, Journal of Virology.

Alphavirus Particle-Based Vaccine Vectors

P. Mason, S. Balsitis, C. Beard, 2011 .

Evaluation of replicative capacity and genetic stability of West Nile virus replicons using highly efficient packaging cell lines.

P. Mason, I. Frolov, O. Petrakova, 2006, Virology.

Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection.

E. Paoletti, E. Konishi, P. Mason, 1992, Virology.

Identiﬁcation and Characterization of a cis -Acting Replication Element ( cre ) Adjacent to the Internal Ribosome Entry Site of Foot-and-Mouth Disease Virus

P. Mason, T. Henry, S. V. Bezborodova, 2002 .

Mutations in West Nile virus nonstructural proteins that facilitate replicon persistence in vitro attenuate virus replication in vitro and in vivo.

P. Mason, N. Bourne, Rafik Z. Fayzulin, 2007, Virology.

Analyses of mutations selected by passaging a chimeric flavivirus identify mutations that alter infectivity and reveal an interaction between the structural proteins and the nonstructural glycoprotein NS1.

P. Mason, D. Widman, R. Suzuki, 2011, Virology.

Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice.

Peter W Mason, P. Mason, A. Carfi, 2014, Vaccine.

Generation and Characterization of a Mammalian Cell Line Continuously Expressing Japanese Encephalitis Virus Subviral Particles

E. Konishi, P. Mason, A. Fujii, 2001, Journal of Virology.

Yellow Fever/Japanese Encephalitis Chimeric Viruses: Construction and Biological Properties

C. Rice, P. Mason, T. Chambers, 1999, Journal of Virology.

Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein.

D. Burke, P. Mason, J. Dalrymple, 1989, The Journal of general virology.

Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes.

P. Mason, B. Baxt, T. Burrage, 1996, Journal of biotechnology.

Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate.

P. Mason, M. Grubman, M. Piccone, 1997, Virology.

Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle

P. Mason, M. Grubman, M. Piccone, 1996, Journal of virology.

Engineering better vaccines for foot-and-mouth disease.

P. Mason, G. Mayr, M. Grubman, 2003, Developments in biologicals.

Construction and Characterization of a Single-Cycle Chimeric Flavivirus Vaccine Candidate That Protects Mice against Lethal Challenge with Dengue Virus Type 2

P. Mason, R. Suzuki, E. Winkelmann, 2008, Journal of Virology.

Third-generation flavivirus vaccines based on single-cycle, encapsidation-defective viruses.

P. Mason, D. Widman, I. Frolov, 2008, Advances in virus research.

Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action.

P. Mason, V. O'Donnell, S. Rossi, 2005, Virology.

West Nile virus: where are we now?

A. Barrett, S. Higgs, P. Mason, 2004, The Lancet. Infectious diseases.

Non-specific antiviral response detected in RNA-treated cultured cells of the sandfly, Lutzomyia longipalpis.

P. Mason, Y. Traub-Cseko, A. Pitaluga, 2008, Developmental and comparative immunology.

West Nile Virus Infection Activates the Unfolded Protein Response, Leading to CHOP

P. Mason, D. Ron, M. Molinari, 2007 .

Genetic transformation and phylogeny of bacterial symbionts from tsetse

C. Woese, R. Tesh, P. Mason, 1993, Insect molecular biology.

MyD 88-Dependent SHIP 1 Regulates Proinflammatory Signaling Pathways in Dendritic Cells after Monophosphoryl Lipid A Stimulation of TLR 4

P. Klenerman, E. Jaffee, L. Boon, 2011 .

A cationic nanoemulsion for the delivery of next-generation RNA vaccines.

C. Mandl, P. Dormitzer, P. Mason, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates

Y. Sakurai, R. Davey, P. Mason, 2018, The Journal of infectious diseases.

West Nile virus genome amplification requires the functional activities of the proteasome

Felicia D Gilfoy, P. Mason, Rafik Z. Fayzulin, 2008, Virology.

The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB.

P. Mason, A. Lilja, 2012, Vaccine.

West Nile Virus-Induced Interferon Production Is Mediated by the Double-Stranded RNA-Dependent Protein Kinase PKR

Felicia D Gilfoy, P. Mason, 2007, Journal of Virology.

Identification and Characterization of a cis-Acting Replication Element (cre) Adjacent to the Internal Ribosome Entry Site of Foot-and-Mouth Disease Virus

P. Mason, T. Henry, S. V. Bezborodova, 2002, Journal of Virology.

Synthetic Generation of Influenza Vaccine Viruses for Rapid Response to Pandemics

Timothy B. Stockwell, Peter W Mason, Thomas Strecker, 2013, Science Translational Medicine.

Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein

E. Konishi, P. Mason, 1993, Journal of virology.

Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans.

E. Konishi, D. Vaughn, P. Mason, 2000, Vaccine.

Potential of ancestral sylvatic dengue-2 viruses to re-emerge.

P. Mason, S. Weaver, K. Hanley, 2007, Virology.

Self-amplifying mRNA vaccines.

C. Mandl, P. Dormitzer, P. Mason, 2015, Advances in genetics.

Salivary gland morphology and virus transmission during long-term cytopathologic West Nile virus infection in Culex mosquitoes.

S. Higgs, P. Mason, B. S. Schneider, 2007, The American journal of tropical medicine and hygiene.

Comparisons of the complete genomes of Asian, African and European isolates of a recent foot-and-mouth disease virus type O pandemic strain (PanAsia).

P. Mason, J. Pacheco, N. Knowles, 2003, The Journal of general virology.

Immunogenicity of RepliVAX WN, a novel single-cycle West Nile virus vaccine.

P. Mason, N. Bourne, G. Milligan, 2010, Vaccine.

Flavivirus type-specific antigens produced from fusions of a portion of the E protein gene with the Escherichia coli trpE gene.

P. Mason, R. Shope, K. Khoshnood, 1991, The American journal of tropical medicine and hygiene.

Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus.

E. Paoletti, E. Konishi, P. Mason, 1991, Virology.

The Anamnestic Neutralizing Antibody Response Is Critical for Protection of Mice from Challenge following Vaccination with a Plasmid Encoding the Japanese Encephalitis Virus Premembrane and Envelope Genes

E. Konishi, P. Mason, I. Kurane, 1999, Journal of Virology.

Enzyme‐linked immunosorbent assay using recombinant antigens for serodiagnosis of Japanese encephalitis

E. Konishi, P. Mason, R. Shope, 1996, Journal of medical virology.

Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes.

E. Konishi, F. Ennis, P. Mason, 1995, The American journal of tropical medicine and hygiene.

Partial nucleotide sequence of the Japanese encephalitis virus genome.

P. Mason, J. Dalrymple, C. Schmaljohn, 1987, Virology.

Expression of Japanese encephalitis virus antigens in Escherichia coli.

P. Mason, J. Dalrymple, P. Mcada, 1987, Virology.

Differential Activation of Human Monocyte-Derived and Plasmacytoid Dendritic Cells by West Nile Virus Generated in Different Host Cells

Felicia D Gilfoy, P. Mason, R. Garofalo, 2007, Journal of Virology.

Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice

D. G. Gibson, J. Gill, Z. Qi, 2013, Emerging Microbes & Infections.

Characterization of synthetic foot-and-mouth disease virus provirions separates acid-mediated disassembly from infectivity

P. Mason, B. Baxt, E. Rieder, 1997, Journal of virology.

A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice.

E. Konishi, P. Mason, I. Kurane, 2000, Vaccine.

A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine.

E. Paoletti, E. Konishi, P. Mason, 1992, Virology.

Immobilization of His-tagged proteins on nickel-chelating nanolipoprotein particles.

P. Mason, B. Chromy, P. Hoeprich, 2009, Bioconjugate chemistry.

Foot-and-mouth disease virus undergoes restricted replication in macrophage cell cultures following Fc receptor-mediated adsorption.

P. Mason, B. Baxt, P. W. Mason, 1995, Virology.

Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV

P. Mason, B. Baxt, J. Lubroth, 1994, Journal of virology.

Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice.

E. Paoletti, P. Mason, R. Shope, 1994, Vaccine.

Synergistic Interactions between the NS3hel and E Proteins Contribute to the Virulence of Dengue Virus Type 1

P. Mason, L. de Noronha, C. N. Duarte Dos Santos, 2012, PLoS neglected tropical diseases.

proteinase of foot-and-mouth disease virus. Identification of the active-site residues of the L

P. Mason, M. Piccone, M. Zellner, 2013 .

Identification of the active-site residues of the 3C proteinase of foot-and-mouth disease virus.

P. Mason, M. Grubman, M. Piccone, 1995, Virology.

Identification of the active-site residues of the L proteinase of foot-and-mouth disease virus

P. Mason, M. Grubman, M. Piccone, 1995, Journal of virology.

Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis.

E. Paoletti, E. Konishi, C. Rice, 1992, Virology.

Construction and Evaluation of a Recombinant Foot‐and‐Mouth Disease Virus

P. Mason, H. G. Rensburg, 2002 .

Construction and evaluation of a recombinant foot-and-mouth disease virus: implications for inactivated vaccine production.

P. Mason, H. V. van Rensburg, 2002, Annals of the New York Academy of Sciences.

Identification of Mutated Cyclization Sequences That Permit Efficient Replication of West Nile Virus Genomes: Use in Safer Propagation of a Novel Vaccine Candidate

P. Mason, R. Suzuki, I. Frolov, 2008, Journal of Virology.

The antigenic structure of dengue type 1 virus envelope and NS1 proteins expressed in Escherichia coli.

P. Mason, T. Mason, M. Fournier, 1990, The Journal of general virology.

Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates.

E. Konishi, F. Ennis, P. Mason, 1998, Vaccine.

West Nile virus replication interferes with both poly(I:C)-induced interferon gene transcription and response to interferon treatment.

P. Mason, F. Scholle, 2005, Virology.

Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system.

T. Ishikawa, P. Mason, D. Widman, 2008, Vaccine.

A recombinant canarypox virus protects rabbits against a lethal rabbit hemorrhagic disease virus (RHDV) challenge.

E. Paoletti, P. Mason, L. Fischer, 1997, Vaccine.

Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice.

E. Konishi, P. Mason, I. Kurane, 2003, Vaccine.

Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.

E. Konishi, F. Ennis, P. Mason, 1997, Virology.

Repeated In Vivo Stimulation of T and B Cell Responses in Old Mice Generates Protective Immunity against Lethal West Nile Virus Encephalitis

P. Mason, D. Widman, J. Nikolich-Žugich, 2011, The Journal of Immunology.

Steep rebound of chloroquine sensitive Plasmodium falciparum in Zimbabwe.

P. Mason, W. Moss, S. Munyati, 2020, The Journal of infectious diseases.

Evaluation of Genetically Engineered Derivatives of a Chinese Strain of Foot-and-Mouth Disease Virus Reveals a Novel Cell-Binding Site Which Functions in Cell Culture and in Animals

P. Mason, J. Pacheco, Qizu Zhao, 2003, Journal of Virology.

Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells

P. Mason, M. Roivainen, B. Baxt, 1995, Journal of virology.

Subcellular distribution of the foot-and-mouth disease virus 3A protein in cells infected with viruses encoding wild-type and bovine-attenuated forms of 3A.

P. Mason, V. O'Donnell, J. Pacheco, 2001, Virology.

Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene.

T. Ishikawa, P. Mason, D. Widman, 2011, Vaccine.

Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling.

T. Ishikawa, P. Mason, D. Widman, 2012, Vaccine.

Sindbis vectors suppress secretion of subviral particles of Japanese encephalitis virus from mammalian cells infected with SIN-JEV recombinants.

P. Mason, T. Frey, K. Pugachev, 1995, Virology.

Recombination of host cell mRNA with the Asia 1 foot-and-mouth disease virus genome in cell suspension culture

P. Mason, P. Sun, H. Bao, 2018, Archives of Virology.

Mutations at positions 186 and 194 in the HA gene of the 2009 H1N1 pandemic influenza virus improve replication in cell culture and eggs

C. Mandl, E. Settembre, P. Dormitzer, 2010, Virology Journal.

Control of alphavirus-based gene expression using engineered riboswitches.

C. Smolke, P. Mason, C. Beard, 2015, Virology.

Nonviral delivery of self-amplifying RNA vaccines

C. Mandl, R. Rappuoli, P. Dormitzer, 2012, Proceedings of the National Academy of Sciences.

A cationic nanoemulsion for the delivery of next-generation RNA vaccines.

C. Mandl, P. Dormitzer, P. Mason, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

RNA-based vaccines.

C. Mandl, P. Mason, J. Ulmer, 2012, Vaccine.

Synthetic Generation of Influenza Vaccine Viruses for Rapid Response to Pandemics

Timothy B. Stockwell, D. G. Gibson, J. Glass, 2013, Science Translational Medicine.

Recombination of host cell mRNA with the Asia 1 foot-and-mouth disease virus genome in cell suspension culture

P. Mason, P. Sun, H. Bao, 2018, Archives of Virology.

RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters.

T. Ishikawa, P. Mason, D. Widman, 2009, Vaccine.

Evaluation of RepliVAX WN, a single-cycle flavivirus vaccine, in a non-human primate model of West Nile virus infection.

T. Ishikawa, R. Tesh, P. Mason, 2010, The American journal of tropical medicine and hygiene.

Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system.

T. Ishikawa, P. Mason, D. Widman, 2008, Vaccine.

Simultaneous Detection of Avian Influenza Virus NP and H5 Antibodies in Chicken Sera Using a Fluorescence Microsphere Immunoassay

P. Mason, B. Lupiani, S. Reddy, 2010, Avian diseases.

Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis.

T. Ishikawa, E. Konishi, P. Mason, 2008, Vaccine.